EPL Ltd Q1 FY2026 Concall Summary

Key Takeaways

• 12th straight quarter of margin expansion: EBITDA margin hit 20.5%, up 18.1% YoY, with Europe and Americas delivering significant improvement after structural fixes.
• Beauty & Cosmetics is the growth engine: The segment surged 35% YoY, driven by innovation-led customer acquisition, and management is confident the momentum is sustainable.
• Europe turnaround is real: After years of sluggishness, a revamped sales structure and cost-base fix delivered 15% growth, with small market share leaving ample room to run.
• Balance sheet is loaded for M&A: Net debt-to-EBITDA fell to 0.45, and management is actively hunting for beauty and cosmetics acquisitions, ready to pursue even a large target.
• What to watch next quarter: Whether the promised H2 oral care recovery materializes, the pace of Thailand's greenfield ramp, and any concrete M&A movement given signed NDAs.

Beauty & Cosmetics: The Strategic Pivot

• Innovation-led growth, not just share of wallet: B&C's 35% surge came from demonstrating new capabilities to existing customers to win new projects, while aggressively adding new customers. Management attributes the confidence in sustaining this run to its innovation-driven nature rather than a one-time pipeline fill.
• Brazil capacity doubled and already delivering: The greenfield facility was running at high utilization, so B&C capacity was doubled and fully came on stream in June. Strong B&C momentum in Brazil is making a material difference to global performance.
• Thailand greenfield targets the B&C prize: Thailand is a large tube market where EPL has tiny share via exports from China. Onshore production unlocks larger-diameter B&C tubes with short lead times that an export model cannot serve. The plan is to start small and accelerate fast, with contribution beginning in H2.
• M&A appetite is focused and funded: Management is "hungry" for M&A in beauty and cosmetics, hunting globally for geographic gap-fillers or extruded-tube manufacturers in predominantly extruded markets. NDAs are already signed on several opportunities.

Kripalu: "We are also hungry today for M&A in the beauty and cosmetics space, and we are actually hunting down opportunities in B&C around the world."

Regional Performance & the Europe Fix

• Europe's P&L was the real bottleneck: For years, suboptimal margins forced management to fix the cost base rather than pursue growth. Both the profit structure and the organization have been reset in the last 12-15 months, and the revenue line is now responding.
• AMESA's oral care softness is seen as temporary: Key customers are signaling recovery, and H2 is expected to bounce back. Management's view is that toothpaste is not a category that disappears, so when oral trends return, the established B&C growth will keep the company squarely in double-digit territory.

Kripalu: "You see the indication we have from our key customers is that they are seeing recovery and H2 is expected to start bouncing back."

Margins & Capital Allocation

• Margin walk: EBITDA margin reached 20.5%, the fourth consecutive quarter above 20%. Europe and Americas delivered the sharpest improvement through structural cost actions and better product mix, while AMESA and EAP stayed within their target ranges on disciplined execution.
• PAT leverage is even sharper: Underlying PAT grew 55.8% YoY, with EPS moving from INR2.02 to INR3.13, reflecting the compounding effect of revenue growth, margin expansion and a tax rate that may run slightly below the 18-20% steady-state range this year.
• Capex stays disciplined: Annual capex will run roughly equal to depreciation at INR350-400 crores, with the large part directed to growth. Normal expansion capex is underway across geographies.
• Balance sheet capacity is a deliberate weapon: Net debt-to-EBITDA improved to 0.45 and ROCE to 18.9%. Management is explicit that this leverage headroom exists to fund M&A, and they are ready for a medium-sized or even larger target.

Kripalu: "Our debt-to-EBITDA ratio is 0.45. So we have huge opportunity to leverage our balance sheet. And we would be ready for even a medium-sized or even a larger potential target because our balance sheet permits us to do so."

Personal Care & Sustainability

• Personal Care delivered 28% YoY growth: Aggressive customer acquisition and innovation, particularly Neo-seam, are showing results. Execution has permeated across the organization globally, though management declined to put a timeline on the sustainability of this run rate.
• Sustainable tubes reached 38% of sales: Growing customer adoption and product innovation are driving the shift, with further tailwinds expected as large brands accelerate their sustainability commitments.
• Indorama partnership is deepening: The strategic investor is supporting the Thailand project with licenses and approvals, and EPL is continuously exploring other collaborative opportunities around the world. On the question of whether Indorama might increase its stake, management had no answer.

Guidance & Commitments

Key Metrics